US Import Tariffs: With 25% Threat, Indian Industry Reads Between Trump Lines

About Half Of Generics Supply From India

 
• By Vibha Ravi
  
Trump's Threat Of US Import Tariffs Looms Large On The Pharma Landscape
Trump's Threat Of US Import Tariffs Looms Large On The Pharma Landscape
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Focus On Asia